With Prof Allan H. Young (UK)
Date: Wed 11 December 2024 @ 7:00pm
Location: Webinar (online)
Don’t miss out – Get your tickets early!
Join our upcoming FREE Webinar with Professor Allan H. Young (UK).
Mood disorders are a common, chronic, severe, complex and costly group of recurrent psychiatric illness that can be devastating for the affected individual and their families. There is a significant clinical need for more effective and better tolerated drug treatments for mood disorders. Although the pathophysiology and neurobiological processes responsible for mood disorders are not fully understood, a greater understanding of the causative underlying mechanisms is gradually emerging. Future advances are expected based on the ability to manipulate and redress the fundamental disease processes and neurobiological dysfunction that underlie these disorders.
In this webinar you will learn:
EVENT DETAILS
DATE: 11th December 2024
TIME: 6:55pm (AEDT) for 7:00pm start, finishing at 8:15pm
DURATION: 75 minutes (incl Q&A)
LOCATION: Online – a link will be emailed to you with the viewing details
MB, ChB, MPhil, PhD, FRCP (Edin), FRCPC, FRCPsych
Allan Young is Chair of Mood Disorders and Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry, Psychology and Neuroscience at King’s College London, where he is also Head of School for Academic Psychiatry. The School of Academic Psychiatry is second in the world rankings for Psychiatry. He is the clinical academic lead in the Psychological Medicine Clinical Academic Group in the South London and Maudsley NHS Trust, and also Consultant Psychiatrist and Head of the Affective Disorders Service.
Professor Young’s research interests focus on the cause and treatments for severe psychiatric illnesses, particularly mood disorders. He has over 700 peer-reviewed publications, including several books about psychopharmacology and affective disorders. He is editor of the Journal of Psychopharmacology and deputy editor of the British Journal of Psychiatry (Open). His H-index is 126 with over 88000 citations of his papers. Professor Young is a Clarivate Highly Cited Researcher: ranking in the top 1% by citations for field and publication year in the Web of Science™ citation index. Professor Young’s current grant funding exceeds £40 million. Past President of the International Society for Affective Disorders and the British Association of Psychopharmacology and Inaugural Chair of the RCPsych Special Committee for Psychopharmacology. He is a trustee of the Drug Safety Research Unit (DSRU), which is internationally respected for its work in Pharmacovigilance, Pharmacoepidemiology, Risk Management and Training Services.
Disclaimer: Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms (for example Facebook, Instagram or Zoom private and public chat forms during a webinar). Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters.
